https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
188
 
downloads
34
CITE
How to cite this poster:
Greenblatt W, Gilbert P, Mallinckrodt C et al. The value of risk reduction in CNS drug development: use of expected net present value (eNPV) as a model. F1000Posters 2013, 4:274 (poster)

The value of risk reduction in CNS drug development: use of expected net present value (eNPV) as a model

W Greenblatt, P Gilbert, CH Mallinckrodt, JBW Williams, D Popp, J Kane, MJ Detke1
Published 20 May 2013
Author Affiliations
  • Metrics
  • 188 Views
  • 34 Downloads
Browse by related subjects
Published 20 May 2013

The value of risk reduction in CNS drug development: use of expected net present value (eNPV) as a model

[version 1; not peer reviewed]

W Greenblatt, P Gilbert, CH Mallinckrodt, JBW Williams, D Popp, J Kane, MJ Detke1
Author Affiliations
1 MedAvante, USA
Presented at
68th Society of Biological Psychiatry Annual Meeting 2013
Abstract
Competing Interests

No competing interests were disclosed

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.